|
JPS59170313A
(ja)
|
1983-03-14 |
1984-09-26 |
Kurimoto Iron Works Ltd |
スクリ−ンゲ−ト
|
|
JPS6085739U
(ja)
|
1983-11-18 |
1985-06-13 |
クラリオン株式会社 |
テ−プレコ−ダにおけるピンチロ−ラ装置
|
|
JPS6243003U
(enExample)
|
1985-09-05 |
1987-03-14 |
|
|
|
JPH0314566A
(ja)
|
1989-06-09 |
1991-01-23 |
Sankyo Co Ltd |
ベンズイミダゾール誘導体
|
|
US5244912A
(en)
|
1991-03-28 |
1993-09-14 |
Eli Lilly And Company |
6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
|
|
FR2710915B1
(fr)
|
1993-10-04 |
1995-11-24 |
Synthelabo |
Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
|
|
GB9410469D0
(en)
|
1994-05-25 |
1994-07-13 |
Erba Farmitalia |
Imidazolylalkyl derivatives of imidazo (5,1-c) (1,4) benzoxazin-1-one and process for their preparation
|
|
FR2731708B1
(fr)
|
1995-03-13 |
1997-04-30 |
Synthelabo |
Derives de piperidine, leur procede de preparation et leur application en therapeutique
|
|
FR2747678B1
(fr)
|
1996-04-22 |
1998-05-22 |
Synthelabo |
Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique
|
|
US6287693B1
(en)
|
1998-02-25 |
2001-09-11 |
John Claude Savoir |
Stable shaped particles of crystalline organic compounds
|
|
CN1450898A
(zh)
|
2000-04-21 |
2003-10-22 |
法玛西雅厄普约翰美国公司 |
用于治疗纤维肌痛和慢性疲劳综合症的化合物
|
|
KR100786927B1
(ko)
|
2000-06-28 |
2007-12-17 |
스미스클라인비이참피이엘시이 |
습식 분쇄방법
|
|
FR2816619B1
(fr)
|
2000-11-15 |
2003-01-31 |
Sanofi Synthelabo |
Derives de benzimidazole, leur preparation et leur application en therapeutique
|
|
HRP20030081A2
(en)
|
2000-08-08 |
2005-02-28 |
Sanofi-Aventis |
Benzimidazole derivatives, preparation and therapeutic use thereof
|
|
US6919334B2
(en)
|
2002-09-12 |
2005-07-19 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
|
|
RU2342388C2
(ru)
|
2002-11-22 |
2008-12-27 |
Джапан Тобакко Инк. |
Конденсированные бициклические азотсодержащие гетероциклы, обладающие dgat ингибирующим действием
|
|
EP1462103A1
(en)
|
2003-03-25 |
2004-09-29 |
Faust Pharmaceuticals |
NO donors, combination products and uses as modulators of neurotransmitter release
|
|
KR20060129023A
(ko)
|
2004-02-23 |
2006-12-14 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
신규한 헤테로환 화합물
|
|
US7897607B2
(en)
|
2004-04-07 |
2011-03-01 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
|
US7713954B2
(en)
|
2004-09-30 |
2010-05-11 |
Roche Palo Alto Llc |
Compositions and methods for treating cognitive disorders
|
|
DE102005011058A1
(de)
|
2005-03-10 |
2006-09-14 |
Merck Patent Gmbh |
Substituierte Tetrahydro-pyrrolo-chinolinderivate
|
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
|
WO2006129623A1
(ja)
|
2005-05-30 |
2006-12-07 |
Mitsubishi Tanabe Pharma Corporation |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
|
AU2006279034A1
(en)
|
2005-08-05 |
2007-02-15 |
Astrazeneca Ab |
Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
|
|
EP2147310A4
(en)
|
2007-04-27 |
2010-09-08 |
Univ Rochester |
COMPOSITIONS AND METHODS OF INHIBITING G-PROTEIN SIGNALING
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
WO2009020559A2
(en)
|
2007-08-03 |
2009-02-12 |
The J. David Gladstone Institutes |
Agents that inhibit p-tefb interactions and methods of use thereof
|
|
US8476260B2
(en)
|
2007-12-28 |
2013-07-02 |
Mitsubishi Tanabe Pharma Corporation |
Antitumor agent
|
|
DE102008052618A1
(de)
|
2008-10-21 |
2010-04-22 |
Henkel Ag & Co. Kgaa |
Tricyclische Aldehyde und C,H-acide Verbindungen
|
|
EP2415767B1
(en)
|
2009-03-27 |
2014-09-03 |
Takeda Pharmaceutical Company Limited |
Poly (ADP-ribose) Polymerase (PARP) Inhibitors
|
|
TW201103941A
(en)
|
2009-06-10 |
2011-02-01 |
Janssen Pharmaceutica Nv |
Benzimidazole derivatives useful as TRPM8 channel modulators
|
|
TW201105681A
(en)
|
2009-06-10 |
2011-02-16 |
Janssen Pharmaceutica Nv |
Benzimidazole derivatives useful as TRPM8 channel modulators
|
|
WO2011024987A1
(ja)
|
2009-08-31 |
2011-03-03 |
塩野義製薬株式会社 |
芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
SI2496582T1
(sl)
|
2009-11-05 |
2016-04-29 |
Glaxosmithkline Llc Corporation Service Company |
Benzodiazepinski inhibitor bromodomene
|
|
US9360482B2
(en)
|
2009-11-05 |
2016-06-07 |
Glaxosmithkline Llc |
Process for the identification of a compound which inhibits the binding of the second bromodomain of each of human BRD-2, BRD-3, and BRD-4
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2496580B1
(en)
|
2009-11-05 |
2013-12-11 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
KR20130069640A
(ko)
|
2010-04-23 |
2013-06-26 |
키네타, 인크. |
항-바이러스 화합물
|
|
MX384074B
(es)
|
2010-05-14 |
2025-03-12 |
Dana Farber Cancer Inst Inc |
Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
|
|
MX373121B
(es)
|
2010-05-14 |
2020-04-30 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
|
JP5913292B2
(ja)
|
2010-05-14 |
2016-04-27 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
代謝を調節する組成物および方法
|
|
ES2526671T3
(es)
|
2010-06-22 |
2015-01-14 |
Glaxosmithkline Llc |
Compuestos de benzotriazoldiazepina inhibidores de bromodominios
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
RU2013138835A
(ru)
|
2011-02-09 |
2015-03-20 |
Ф. Хоффманн-Ля Рош Аг |
Гетероциклические соединения в качестве ингибиторов pi3 киназы
|
|
CA2828212A1
(en)
|
2011-02-23 |
2012-08-30 |
Shiraz Mujtaba |
Inhibitors of bromodomains as modulators of gene expression
|
|
BR112013024122A2
(pt)
|
2011-03-21 |
2019-09-24 |
Hoffmann La Roche |
compostos de benzoxazepina seletivos para p110 delta pi3k e métodos de uso
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2705039B1
(en)
|
2011-05-04 |
2017-07-26 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
CA2840380A1
(en)
|
2011-06-24 |
2012-12-27 |
Dana-Farber Cancer Institute, Inc. |
Selective inhibitors of histone deacetylase isoform 6 and methods thereof
|
|
JP2013010719A
(ja)
|
2011-06-30 |
2013-01-17 |
Dainippon Sumitomo Pharma Co Ltd |
ベンズイミダゾロンおよびオキシインドール誘導体ならびにそれらの医薬用途
|
|
JP2014524409A
(ja)
|
2011-07-29 |
2014-09-22 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
Ｈｉｖの治療のための組成物および方法
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
MY165004A
(en)
|
2011-08-31 |
2018-02-28 |
Otsuka Pharma Co Ltd |
Quinolone compound
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
US9012642B2
(en)
|
2011-09-22 |
2015-04-21 |
Viiv Healthcare Uk Limited |
Pyrrolopyridinone compounds and methods for treating HIV
|
|
CN103857391B
(zh)
|
2011-09-30 |
2016-06-08 |
沈阳蓝桑医药生物技术研发有限公司 |
含有瑞利格内酯的药物组合物及其应用
|
|
WO2013060636A1
(en)
|
2011-10-25 |
2013-05-02 |
Sanofi |
6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
WO2013097052A1
(en)
*
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
WO2013148197A1
(en)
|
2012-03-28 |
2013-10-03 |
The J. David Gladstone Institutes |
Compositions and methods for reactivating latent immunodeficiency virus
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
EP2838881B1
(en)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolone derivatives
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
WO2013185284A1
(en)
|
2012-06-12 |
2013-12-19 |
Abbott Laboratories |
Pyridinone and pyridazinone derivatives
|
|
RU2659171C2
(ru)
|
2012-06-25 |
2018-06-28 |
Онкоэтикс Гмбх |
Способ лечения лимфомы, применяя тиенотриазолодиазепиновые соединения
|
|
US9610332B2
(en)
|
2012-07-18 |
2017-04-04 |
Massachusetts Institute Of Technology |
Compositions and methods for modulating BRD4 bioactivity
|
|
JP2015524847A
(ja)
|
2012-08-16 |
2015-08-27 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ |
小細胞肺がんを治療するためのベンゾジアゼピン
|
|
PE20150729A1
(es)
|
2012-08-16 |
2015-06-14 |
Bayer Pharma AG |
2,3-benzodiazepines
|
|
HK1208448A1
(en)
|
2012-09-28 |
2016-03-04 |
Bayer Pharma Aktiengesellschaft |
Bet protein-inhibiting 5-aryl triazole azepines
|
|
MX2015003771A
(es)
|
2012-09-28 |
2016-03-04 |
Oncoethix Gmbh |
Formulacion farmaceutica que contiene compuestos de tienotriazolodiazepina.
|
|
US9409893B2
(en)
|
2012-11-09 |
2016-08-09 |
Jacobus Pharmaceutical Company, Inc. |
Heteroaryl derivatives and uses thereof
|
|
US9422290B2
(en)
|
2012-11-13 |
2016-08-23 |
Boehringer Ingelheim International Gmbh |
Triazolopyridazine
|
|
ES2625945T3
(es)
|
2012-11-14 |
2017-07-21 |
Glaxosmithkline Llc |
Tieno[3,2-c]piridin-4(5H)-onas como inhibidores de bet
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
CN105229002A
(zh)
|
2012-12-20 |
2016-01-06 |
拜耳医药股份有限公司 |
抑制bet蛋白的二氢吡啶并吡嗪酮
|
|
US20150344444A1
(en)
|
2012-12-20 |
2015-12-03 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroxyquinoxalinones
|
|
US9271978B2
(en)
|
2012-12-21 |
2016-03-01 |
Zenith Epigenetics Corp. |
Heterocyclic compounds as bromodomain inhibitors
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
JP6404838B2
(ja)
|
2013-02-27 |
2018-10-17 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ブロモドメイン阻害剤として有用なカルバゾール化合物
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
JP2016512524A
(ja)
|
2013-03-11 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ブロモドメイン阻害剤
|
|
EP2970285B1
(en)
|
2013-03-11 |
2019-04-17 |
AbbVie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
JP6401773B2
(ja)
|
2013-03-11 |
2018-10-10 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｂｅｔブロモドメイン阻害剤およびこれを用いる治療方法
|
|
WO2014165143A1
(en)
|
2013-03-12 |
2014-10-09 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone bromodomain inhibitors
|
|
WO2014165127A1
(en)
|
2013-03-12 |
2014-10-09 |
Abbvie Inc. |
Pyrrole amide inhibitors
|
|
CN105026403B
(zh)
|
2013-03-12 |
2018-05-18 |
艾伯维公司 |
四环布罗莫结构域抑制剂
|
|
ES2704048T3
(es)
|
2013-03-14 |
2019-03-14 |
Glaxosmithkline Ip No 2 Ltd |
Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina-2,3-disustituida y su uso como inhibidores de bromodominio
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
JP6280573B2
(ja)
|
2013-03-14 |
2018-02-14 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ |
ブロモドメイン阻害薬としてのフロピリジン
|
|
WO2014159837A1
(en)
|
2013-03-14 |
2014-10-02 |
Convergene Llc |
Methods and compositions for inhibition of bromodomain-containing proteins
|
|
HRP20181392T1
(hr)
|
2013-03-15 |
2018-10-19 |
Plexxikon Inc. |
Heterociklični spojevi i njihova uporaba
|
|
WO2014152029A2
(en)
|
2013-03-15 |
2014-09-25 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
US9227985B2
(en)
|
2013-03-15 |
2016-01-05 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
EP2978757B1
(en)
|
2013-03-27 |
2017-02-08 |
Boehringer Ingelheim International GmbH |
Indolinone analogues as brd4 inhibitors
|
|
US9199988B2
(en)
|
2013-03-27 |
2015-12-01 |
Boehringer Ingelheim International Gmbh |
Dihydroquinazolinone analogues
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
WO2014170350A1
(en)
|
2013-04-17 |
2014-10-23 |
Albert Ludwigs Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
WO2014173241A1
(en)
|
2013-04-26 |
2014-10-30 |
Beigene, Ltd. |
Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
CA2913697A1
(en)
|
2013-05-27 |
2014-12-04 |
Novartis Ag |
Imidazopyrrolidinone derivatives and their use in the treatment of disease
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
CA2912986A1
(en)
|
2013-05-28 |
2014-12-04 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
|
|
CA2912991A1
(en)
|
2013-05-28 |
2014-12-04 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
|
|
ITMI20130991A1
(it)
|
2013-06-17 |
2014-12-18 |
Industrie De Nora Spa |
Sistema per la misurazione di correnti presenti sugli elettrodi in celle elettrolitiche interconnesse.
|
|
CN105492436A
(zh)
|
2013-06-17 |
2016-04-13 |
拜耳制药股份公司 |
取代的苯基-2,3-苯并二氮杂环庚三烯
|
|
SG11201510409QA
(en)
|
2013-06-21 |
2016-01-28 |
Zenith Epigenetics Corp |
Novel bicyclic bromodomain inhibitors
|
|
WO2015004533A2
(en)
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
AR096758A1
(es)
*
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
PE20160540A1
(es)
|
2013-06-28 |
2016-06-11 |
Abbvie Inc |
Inhibidores de bromodominios
|
|
EP3019502B1
(en)
|
2013-07-08 |
2017-05-17 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
US10479777B2
(en)
|
2013-07-16 |
2019-11-19 |
Basf Se |
Herbicidal azines
|
|
WO2015013635A2
(en)
|
2013-07-25 |
2015-01-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
KR101672096B1
(ko)
|
2013-09-30 |
2016-11-02 |
주식회사 엘지화학 |
헤테로환 화합물 및 이를 포함하는 유기 발광 소자
|
|
DK3290407T3
(da)
|
2013-10-18 |
2020-03-23 |
Celgene Quanticel Res Inc |
Bromodomæneinhibitorer
|
|
US20150148372A1
(en)
|
2013-11-26 |
2015-05-28 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
US9428514B2
(en)
|
2013-12-09 |
2016-08-30 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
US9309246B2
(en)
|
2013-12-19 |
2016-04-12 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
WO2015095445A1
(en)
*
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
JP6480944B2
(ja)
|
2014-01-09 |
2019-03-13 |
オリオン コーポレーション |
ブロモドメイン阻害剤としての二環式複素環誘導体
|
|
JP2017511801A
(ja)
|
2014-02-28 |
2017-04-27 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
ＢＥＴブロモドメイン阻害剤としての９Ｈ−ピリミド［４，５−ｂ］インドールおよび関連類似体
|
|
CN106232595B
(zh)
|
2014-04-23 |
2020-01-14 |
巴斯夫欧洲公司 |
作为除草剂的二氨基三嗪化合物
|
|
MY180775A
(en)
|
2014-04-23 |
2020-12-09 |
Incyte Corp |
1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins
|
|
TWI664165B
(zh)
|
2014-04-23 |
2019-07-01 |
日商武田藥品工業股份有限公司 |
含氮雜環化合物
|
|
EP3137086A4
(en)
|
2014-05-02 |
2017-12-27 |
Oncoethix GmbH |
Method of treating resistant non-hodgkin lymphoma, medulloblastoma, and/or alk+non-small cell lung cancer using thienotriazolodiazepine compounds
|
|
KR20160145833A
(ko)
|
2014-05-02 |
2016-12-20 |
온코에틱스 게엠베하 |
티에노트리아졸로디아제핀 화합물을 사용한 급성 골수성 백혈병 및/또는 급성 림프아구성 백혈병의 치료 방법
|
|
WO2015169953A1
(en)
|
2014-05-08 |
2015-11-12 |
Oncoethix Gmbh |
Method of treating glioma using thienotriazolodiazepine compounds
|
|
BR112016026046A8
(pt)
|
2014-05-08 |
2021-07-20 |
Oncoethix Gmbh |
uso de compostos de tienotriazolodiazepina
|
|
US10065951B2
(en)
|
2014-05-30 |
2018-09-04 |
Icahn School Of Medicine At Mount Sinai |
Small molecule transcription modulators of bromodomains
|
|
PL3157928T3
(pl)
|
2014-06-20 |
2019-07-31 |
Constellation Pharmaceuticals, Inc. |
Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
|
|
GB2528783B
(en)
|
2014-07-11 |
2019-12-18 |
Jaan Peter Aked Hurditch |
A detachable leash handle
|
|
US9527864B2
(en)
|
2014-09-15 |
2016-12-27 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
AR102426A1
(es)
|
2014-10-24 |
2017-03-01 |
Bristol Myers Squibb Co |
Compuestos de indolcarboxamida como inhibidores de btk
|
|
MA40943A
(fr)
*
|
2014-11-10 |
2017-09-19 |
Constellation Pharmaceuticals Inc |
Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
|
|
CA2974153A1
(en)
|
2015-02-03 |
2016-08-11 |
Trillium Therapeutics Inc. |
Fluorinated imidazo[4,5-c]quinoline derivatives as inhibitors of bromodomain containing proteins
|
|
WO2016186453A1
(en)
|
2015-05-20 |
2016-11-24 |
Kainos Medicine, Inc. |
Quinoline derivatives as bromodomain inhibitors
|
|
EP3305789A4
(en)
|
2015-05-29 |
2018-11-21 |
Shionogi & Co., Ltd. |
Nitrogen-containing tricyclic derivative having hiv replication inhibitory activity
|
|
CN105039258B
(zh)
|
2015-07-03 |
2018-04-17 |
北京大学 |
将非神经元细胞重编程为神经元样细胞的方法和组合物
|
|
WO2017075377A1
(en)
|
2015-10-29 |
2017-05-04 |
Incyte Corporation |
Amorphous solid form of a bet protein inhibitor
|
|
CN105254635A
(zh)
|
2015-10-30 |
2016-01-20 |
中国药科大学 |
一类咪唑并吡嗪类化合物及其药物组合物和用途
|
|
US20170127985A1
(en)
|
2015-11-11 |
2017-05-11 |
Medtronic Minimed, Inc. |
Sensor set
|
|
CA3007168A1
(en)
|
2015-12-14 |
2017-06-22 |
Zenith Epigenetics Ltd. |
1h-imidazo[4,5-b]pyridinyl and 2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridinyl heterocyclic bet bromodomain inhibitors
|
|
WO2017127930A1
(en)
|
2016-01-28 |
2017-08-03 |
Neomed Institute |
Substituted [1,2,4]triazolo[4,3-a]pyridines, their preparation and their use as pharmaceuticals
|
|
US20190040063A1
(en)
|
2016-02-05 |
2019-02-07 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Tricyclic compound for bromodomain-containing protein inhibitor and preparation pharmaceutical composition, and application thereof
|
|
KR102643344B1
(ko)
|
2016-06-20 |
2024-03-07 |
인사이트 코포레이션 |
Bet 저해제의 결정질 고체 형태
|
|
CN108069958A
(zh)
|
2016-11-10 |
2018-05-25 |
凯惠科技发展(上海)有限公司 |
一种含氮杂环类化合物、其制备方法、药物组合物及应用
|